Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-services domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the woocommerce-payments domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/benchmarkantibodiescom_769/public/wp-includes/functions.php on line 6121
CA19-9 – benchmark antibodies CA19-9
Skip to content
Close

Showing the single result

CA19-9

CA19-9: CA19-9 is a tumor marker often elevated in pancreatic cancer. Its detection assists in monitoring disease progression and response to therapy in pancreatic cancer patients.



target type reactivity applications
6045 CA19-9 mouse monoclonal (121SLE) human IHC

Human colon carcinoma stained with anti-CA19-9 antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic staining of tumor cells.
IHC with antibody [6045] : Human colon carcinoma stained with anti-CA19-9 antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic staining of tumor cells.
ICC
IHC